The transferrin receptor TFRC is highly expressed in bladder cancer with diagnostic and prognostic value, and the repressed expression of TFRC could inhibit ferroptosis induced by Erastin in bladder cancer cells [87]. This evidence concerns the gene TFRC and urinary bladder cancer.